Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Feb 20, 2021 6:15pm
439 Views
Post# 32619893

No way, Medivolve share prices stay at these levels

No way, Medivolve share prices stay at these levels

Medivolve should stop buying other businesses and issuing shares for them. Good, they cancelled the Karland Health buying deal and they should also cancel the Noble Bioscience deal. As Medivolve share price should go up with the awareness campaign. These people can turn around and flood the market by selling all these free shares. 

 

Medivolve should hold off issuing any new shares until the next 2-3 months. I think by end of the March or early April BloFish trial should be completed and submitted for EUA. By April 200 plus, collection sites should be installed generating $50 million-plus revenue per month. Year-end finances are released at the end of April. Medivolve brand awareness campaign at full speed by April. Medivolve should be trading in Dollars, not cents. At that point, Medivolve can make any needed business acquisitions. Medivolve can buy these businesses by issuing 2 million shares instead of 20 million shares. For now, fewer outstanding shares can calculate into the higher stock price. 

 

Medivolve just hired 3 marketing companies to build collection sites brand and awareness campaign for Medivolve in the investment community. No way, Medivolve share prices stay at these levels for long. I don't think Medivolve spending this much money to get MEDV a few cents higher. All Medivolve needs is to attract people who know how to see forward-looking revenue, calculate EBTIDA margin and use PE ratio. 

 

Medivolve revenue was about $11.6 million in January with 32 collection sites. Future revenue should increase with 62 collection sites in February, 107 in March. The next phase is adding another 70 collection sites starting in early March. https://medivolve.ca/investor-presentation/

 

If anyone doubts Medivolve future trading into $4-5 dollars then find me a company with this kind of revenue and trading under $100 million market cap. This does not include revenue from SANATY IPS Columbia 28% owned by Medivolve. https://www.facebook.com/ipssanaty Also Medivolve owns a 30% stake in Glenco medical corp. They have 5 people working with an online store. So they must be making revenue https://www.glencomedical.com/store/. Then Medivolve have Investment in Dr. Anne-Claude Gingras (Mt. Sinai Hospital), Dr. Samira Mubareka and Dr. Rob Kozak (Sunnybrook Research Institute) 

 

<< Previous
Bullboard Posts
Next >>